Joseph J Guarneri

Title: Joseph J Guarneri: Innovator in Pharmaceutical Compositions

Introduction

Joseph J Guarneri is a notable inventor based in Stamford, CT (US), recognized for his contributions to the field of pharmaceutical compositions. He holds a total of 10 patents, showcasing his innovative approach to drug delivery systems and formulations.

Latest Patents

Among his latest patents, Guarneri has developed microcrystalline diketopiperazine compositions and methods. This invention discloses DKP microcrystals produced by an improved method that prevents irreversible self-assembly into microparticles. The microcrystals can be dispersed through atomization and re-formed by spray drying into particles with spherical shell morphology. These microcrystalline particle compositions are particularly suitable for pulmonary drug delivery of peptides, proteins, nucleic acids, and small organic molecules. Another significant patent involves heat-stable dry powder pharmaceutical compositions and methods. This invention includes stable dry powders containing peptides or proteins, such as oxytocin, designed for pharmaceutical use. These compositions maintain high stability at elevated temperatures and humid environments, making them ideal for storage at room temperature with an extended shelf-life.

Career Highlights

Throughout his career, Guarneri has worked with prominent organizations, including Mannkind Corporation and Torrey Pines Institute for Molecular Studies. His work has significantly impacted the development of innovative drug delivery systems.

Collaborations

Guarneri has collaborated with esteemed colleagues such as Andrea Leone-Bay and Marshall L Grant, contributing to advancements in pharmaceutical research and development.

Conclusion

Joseph J Guarneri's innovative work in pharmaceutical compositions and drug delivery systems has made a lasting impact in the field. His patents reflect a commitment to improving the efficacy and stability of pharmaceutical products.